| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 1.89e-09 | 23 | 47 | 5 | GO:0017128 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.26e-07 | 51 | 47 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 1.27e-07 | 20 | 47 | 4 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 1.27e-07 | 20 | 47 | 4 | GO:0005229 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 8.28e-07 | 74 | 47 | 5 | GO:0005548 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 5.73e-06 | 50 | 47 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride channel activity | 4.97e-05 | 86 | 47 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.31e-05 | 749 | 47 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 9.50e-05 | 196 | 47 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.00e-04 | 103 | 47 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.12e-04 | 125 | 47 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.94e-04 | 11 | 47 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | tumor necrosis factor receptor activity | 3.53e-04 | 12 | 47 | 2 | GO:0005031 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.35e-04 | 151 | 47 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | cytokine binding | 5.04e-04 | 157 | 47 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 6.95e-04 | 171 | 47 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 7.21e-04 | 17 | 47 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | integrin binding | 7.58e-04 | 175 | 47 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.09e-03 | 193 | 47 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | death receptor activity | 1.11e-03 | 21 | 47 | 2 | GO:0005035 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.18e-03 | 197 | 47 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.70e-03 | 26 | 47 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 1.83e-03 | 27 | 47 | 2 | GO:0005227 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 2.41e-03 | 31 | 47 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.68e-03 | 599 | 47 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 2.90e-03 | 34 | 47 | 2 | GO:0050750 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 3.80e-03 | 39 | 47 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.55e-03 | 891 | 47 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.90e-03 | 156 | 47 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 6.09e-03 | 1189 | 47 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.79e-03 | 334 | 47 | 4 | GO:0022836 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 4.65e-06 | 47 | 49 | 4 | GO:0035850 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 1.01e-05 | 57 | 49 | 4 | GO:0061005 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 1.02e-05 | 321 | 49 | 7 | GO:0010001 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 1.66e-05 | 3 | 49 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.31e-05 | 4 | 49 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | glial cell development | 3.49e-05 | 157 | 49 | 5 | GO:0021782 | |
| GeneOntologyBiologicalProcess | regulation of JNK cascade | 3.93e-05 | 161 | 49 | 5 | GO:0046328 | |
| GeneOntologyBiologicalProcess | gliogenesis | 7.07e-05 | 435 | 49 | 7 | GO:0042063 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 8.15e-05 | 445 | 49 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | JNK cascade | 1.05e-04 | 198 | 49 | 5 | GO:0007254 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 1.13e-04 | 105 | 49 | 4 | GO:0048708 | |
| GeneOntologyBiologicalProcess | adaptive immune memory response | 1.15e-04 | 7 | 49 | 2 | GO:0090716 | |
| GeneOntologyBiologicalProcess | positive regulation of JNK cascade | 1.21e-04 | 107 | 49 | 4 | GO:0046330 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.34e-04 | 482 | 49 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.45e-04 | 112 | 49 | 4 | GO:1902476 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.53e-04 | 850 | 49 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.53e-04 | 8 | 49 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | astrocyte development | 1.90e-04 | 47 | 49 | 3 | GO:0014002 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 1.97e-04 | 9 | 49 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.04e-04 | 883 | 49 | 9 | GO:0070848 | |
| GeneOntologyBiologicalProcess | chloride transport | 2.42e-04 | 128 | 49 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 2.42e-04 | 128 | 49 | 4 | GO:0072009 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 2.46e-04 | 10 | 49 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 2.46e-04 | 10 | 49 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 2.64e-04 | 131 | 49 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 2.88e-04 | 134 | 49 | 4 | GO:0098661 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 3.00e-04 | 11 | 49 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | bone development | 3.98e-04 | 264 | 49 | 5 | GO:0060348 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 4.00e-04 | 1186 | 49 | 10 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast development | 4.24e-04 | 13 | 49 | 2 | GO:2001204 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 4.24e-04 | 13 | 49 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 4.24e-04 | 13 | 49 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 4.53e-04 | 63 | 49 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 4.76e-04 | 153 | 49 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 4.94e-04 | 14 | 49 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | regulation of collagen biosynthetic process | 4.96e-04 | 65 | 49 | 3 | GO:0032965 | |
| GeneOntologyBiologicalProcess | axon guidance | 5.64e-04 | 285 | 49 | 5 | GO:0007411 | |
| GeneOntologyBiologicalProcess | extracellular matrix constituent secretion | 5.69e-04 | 15 | 49 | 2 | GO:0070278 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 5.73e-04 | 286 | 49 | 5 | GO:0097485 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 5.90e-04 | 162 | 49 | 4 | GO:0072073 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 6.52e-04 | 449 | 49 | 6 | GO:0050900 | |
| GeneOntologyBiologicalProcess | respiratory system development | 7.66e-04 | 305 | 49 | 5 | GO:0060541 | |
| GeneOntologyBiologicalProcess | nephron development | 7.71e-04 | 174 | 49 | 4 | GO:0072006 | |
| GeneOntologyBiologicalProcess | collagen biosynthetic process | 7.84e-04 | 76 | 49 | 3 | GO:0032964 | |
| GeneOntologyBiologicalProcess | regulation of collagen metabolic process | 8.15e-04 | 77 | 49 | 3 | GO:0010712 | |
| GeneOntologyBiologicalProcess | glomerulus development | 8.15e-04 | 77 | 49 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 8.75e-04 | 180 | 49 | 4 | GO:0015698 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 9.10e-04 | 80 | 49 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 9.30e-04 | 183 | 49 | 4 | GO:0006820 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 1.02e-03 | 20 | 49 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | plasma membrane organization | 1.03e-03 | 188 | 49 | 4 | GO:0007009 | |
| GeneOntologyBiologicalProcess | immunological memory process | 1.13e-03 | 21 | 49 | 2 | GO:0090713 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 1.22e-03 | 197 | 49 | 4 | GO:0030509 | |
| GeneOntologyBiologicalProcess | podocyte differentiation | 1.24e-03 | 22 | 49 | 2 | GO:0072112 | |
| GeneOntologyBiologicalProcess | osteoclast development | 1.24e-03 | 22 | 49 | 2 | GO:0036035 | |
| GeneOntologyBiologicalProcess | bone cell development | 1.24e-03 | 22 | 49 | 2 | GO:0098751 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in metanephros development | 1.24e-03 | 22 | 49 | 2 | GO:0072202 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell differentiation | 1.24e-03 | 22 | 49 | 2 | GO:0072311 | |
| GeneOntologyBiologicalProcess | renal filtration cell differentiation | 1.24e-03 | 22 | 49 | 2 | GO:0061318 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.35e-03 | 23 | 49 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | metanephric nephron epithelium development | 1.35e-03 | 23 | 49 | 2 | GO:0072243 | |
| GeneOntologyBiologicalProcess | glomerular epithelium development | 1.35e-03 | 23 | 49 | 2 | GO:0072010 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.36e-03 | 347 | 49 | 5 | GO:0090092 | |
| GeneOntologyBiologicalProcess | apoptotic signaling pathway | 1.39e-03 | 713 | 49 | 7 | GO:0097190 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 1.48e-03 | 24 | 49 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | metanephros development | 1.50e-03 | 95 | 49 | 3 | GO:0001656 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.54e-03 | 96 | 49 | 3 | GO:0060113 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.59e-03 | 730 | 49 | 7 | GO:0007423 | |
| GeneOntologyBiologicalProcess | positive regulation of Ras protein signal transduction | 1.60e-03 | 25 | 49 | 2 | GO:0046579 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.68e-03 | 215 | 49 | 4 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.68e-03 | 215 | 49 | 4 | GO:0071773 | |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 1.73e-03 | 26 | 49 | 2 | GO:0017121 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 1.73e-03 | 26 | 49 | 2 | GO:0050966 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.77e-03 | 218 | 49 | 4 | GO:0090101 | |
| GeneOntologyBiologicalProcess | kidney development | 1.85e-03 | 372 | 49 | 5 | GO:0001822 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 1.89e-03 | 103 | 49 | 3 | GO:0002437 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.94e-03 | 104 | 49 | 3 | GO:0042490 | |
| GeneOntologyBiologicalProcess | heart development | 1.96e-03 | 757 | 49 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | neuron development | 2.01e-03 | 1463 | 49 | 10 | GO:0048666 | |
| GeneOntologyBiologicalProcess | metanephric epithelium development | 2.01e-03 | 28 | 49 | 2 | GO:0072207 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 2.01e-03 | 28 | 49 | 2 | GO:0051152 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell differentiation | 2.01e-03 | 28 | 49 | 2 | GO:0043011 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 2.05e-03 | 106 | 49 | 3 | GO:0051149 | |
| GeneOntologyBiologicalProcess | ossification | 2.06e-03 | 562 | 49 | 6 | GO:0001503 | |
| GeneOntologyBiologicalProcess | renal system development | 2.17e-03 | 386 | 49 | 5 | GO:0072001 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 2.23e-03 | 571 | 49 | 6 | GO:0043410 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 2.27e-03 | 110 | 49 | 3 | GO:0072080 | |
| GeneOntologyBiologicalProcess | protein refolding | 2.30e-03 | 30 | 49 | 2 | GO:0042026 | |
| GeneOntologyBiologicalProcess | ossification involved in bone maturation | 2.30e-03 | 30 | 49 | 2 | GO:0043931 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 2.30e-03 | 30 | 49 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 2.46e-03 | 31 | 49 | 2 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 2.46e-03 | 31 | 49 | 2 | GO:0061437 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.51e-04 | 656 | 50 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.54e-04 | 658 | 50 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | chloride channel complex | 3.44e-04 | 57 | 50 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | microfibril | 4.30e-04 | 13 | 50 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | cholinergic synapse | 1.26e-03 | 22 | 50 | 2 | GO:0098981 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.59e-03 | 530 | 50 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.57e-03 | 583 | 50 | 6 | GO:0097060 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 1.46e-05 | 2 | 20 | 2 | HP:0005900 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | 3.20e-05 | 474 | 20 | 9 | HP:0006493 | |
| HumanPheno | Sudanophilic leukodystrophy | 4.38e-05 | 3 | 20 | 2 | HP:0003269 | |
| MousePheno | abnormal glomerular filtration barrier function | 5.27e-05 | 4 | 42 | 2 | MP:0011856 | |
| MousePheno | large mandible | 5.27e-05 | 4 | 42 | 2 | MP:0030050 | |
| MousePheno | abnormal thoracic cage morphology | 5.97e-05 | 463 | 42 | 8 | MP:0004624 | |
| MousePheno | abnormal ulna morphology | 1.14e-04 | 84 | 42 | 4 | MP:0005108 | |
| MousePheno | abnormal bone remodeling | 1.84e-04 | 178 | 42 | 5 | MP:0002998 | |
| MousePheno | abnormal vertebrae morphology | 1.88e-04 | 546 | 42 | 8 | MP:0000137 | |
| MousePheno | abnormal trabecular bone morphology | 2.08e-04 | 289 | 42 | 6 | MP:0000130 | |
| MousePheno | abnormal axial skeleton morphology | FAT4 FBN1 TENM4 CRIM1 SACS ANO6 ANO5 CCN2 LTBP1 LTBP3 PLP1 NOTCH1 NOTCH2 | 2.30e-04 | 1458 | 42 | 13 | MP:0002114 |
| MousePheno | abnormal forelimb zeugopod morphology | 2.42e-04 | 102 | 42 | 4 | MP:0003855 | |
| MousePheno | absent follicular dendritic cells | 2.44e-04 | 8 | 42 | 2 | MP:0008201 | |
| MousePheno | abnormal appendicular skeleton morphology | 2.49e-04 | 896 | 42 | 10 | MP:0009250 | |
| MousePheno | increased kidney apoptosis | 2.86e-04 | 43 | 42 | 3 | MP:0011368 | |
| MousePheno | decreased kidney cell proliferation | 3.13e-04 | 9 | 42 | 2 | MP:0011441 | |
| MousePheno | decreased follicular dendritic cell number | 3.91e-04 | 10 | 42 | 2 | MP:0008200 | |
| Domain | EGF | FAT4 FBN1 MALRD1 TENM4 TENM3 WIF1 LAMB2 LAMC3 LTBP1 LTBP3 NOTCH1 NOTCH2 | 4.21e-13 | 235 | 47 | 12 | SM00181 |
| Domain | EGF-like_dom | FAT4 FBN1 MALRD1 TENM4 TENM3 WIF1 LAMB2 LAMC3 LTBP1 LTBP3 NOTCH1 NOTCH2 | 8.36e-13 | 249 | 47 | 12 | IPR000742 |
| Domain | EGF_1 | FAT4 FBN1 MALRD1 TENM4 TENM3 WIF1 LAMB2 LAMC3 LTBP1 LTBP3 NOTCH1 NOTCH2 | 1.11e-12 | 255 | 47 | 12 | PS00022 |
| Domain | EGF-like_CS | FAT4 FBN1 MALRD1 TENM4 TENM3 WIF1 LAMB2 LAMC3 LTBP1 LTBP3 NOTCH1 NOTCH2 | 1.46e-12 | 261 | 47 | 12 | IPR013032 |
| Domain | EGF_2 | FAT4 FBN1 MALRD1 TENM4 TENM3 WIF1 LAMB2 LAMC3 LTBP1 LTBP3 NOTCH1 NOTCH2 | 1.75e-12 | 265 | 47 | 12 | PS01186 |
| Domain | Growth_fac_rcpt_ | 4.91e-12 | 156 | 47 | 10 | IPR009030 | |
| Domain | EGF_3 | 2.83e-10 | 235 | 47 | 10 | PS50026 | |
| Domain | Anoct_dimer | 1.22e-09 | 7 | 47 | 4 | PF16178 | |
| Domain | Anoct_dimer | 1.22e-09 | 7 | 47 | 4 | IPR032394 | |
| Domain | Anoctamin | 7.31e-09 | 10 | 47 | 4 | PF04547 | |
| Domain | Anoctamin | 7.31e-09 | 10 | 47 | 4 | IPR007632 | |
| Domain | hEGF | 7.63e-09 | 28 | 47 | 5 | PF12661 | |
| Domain | EGF_CA | 7.37e-08 | 86 | 47 | 6 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.52e-07 | 97 | 47 | 6 | IPR018097 | |
| Domain | EGF_CA | 1.71e-07 | 99 | 47 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.82e-07 | 100 | 47 | 6 | PS00010 | |
| Domain | TNFR_c6 | 2.49e-07 | 22 | 47 | 4 | PF00020 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.58e-07 | 106 | 47 | 6 | IPR000152 | |
| Domain | TNFR | 5.05e-07 | 26 | 47 | 4 | SM00208 | |
| Domain | TB | 5.19e-07 | 7 | 47 | 3 | PF00683 | |
| Domain | EGF_CA | 5.92e-07 | 122 | 47 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.52e-07 | 124 | 47 | 6 | IPR001881 | |
| Domain | TNFR_NGFR_1 | 7.98e-07 | 29 | 47 | 4 | PS00652 | |
| Domain | TNFR_NGFR_2 | 7.98e-07 | 29 | 47 | 4 | PS50050 | |
| Domain | - | 8.29e-07 | 8 | 47 | 3 | 3.90.290.10 | |
| Domain | TB | 1.24e-06 | 9 | 47 | 3 | PS51364 | |
| Domain | TB_dom | 1.24e-06 | 9 | 47 | 3 | IPR017878 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 1.37e-06 | 33 | 47 | 4 | IPR001368 | |
| Domain | EGF_extracell | 1.55e-05 | 60 | 47 | 4 | IPR013111 | |
| Domain | EGF_2 | 1.55e-05 | 60 | 47 | 4 | PF07974 | |
| Domain | EGF | 1.58e-05 | 126 | 47 | 5 | PF00008 | |
| Domain | Rhs_assc_core | 1.86e-05 | 3 | 47 | 2 | IPR022385 | |
| Domain | Fas_rcpt | 1.86e-05 | 3 | 47 | 2 | IPR008063 | |
| Domain | DUF3454 | 1.86e-05 | 3 | 47 | 2 | PF11936 | |
| Domain | DUF3454_notch | 1.86e-05 | 3 | 47 | 2 | IPR024600 | |
| Domain | DUF3454 | 1.86e-05 | 3 | 47 | 2 | SM01334 | |
| Domain | Tox-GHH_dom | 3.71e-05 | 4 | 47 | 2 | IPR028916 | |
| Domain | TENEURIN_N | 3.71e-05 | 4 | 47 | 2 | PS51361 | |
| Domain | NOD | 3.71e-05 | 4 | 47 | 2 | PF06816 | |
| Domain | Notch | 3.71e-05 | 4 | 47 | 2 | IPR008297 | |
| Domain | Ten_N | 3.71e-05 | 4 | 47 | 2 | IPR009471 | |
| Domain | NODP | 3.71e-05 | 4 | 47 | 2 | PF07684 | |
| Domain | Tox-GHH | 3.71e-05 | 4 | 47 | 2 | PF15636 | |
| Domain | Ten_N | 3.71e-05 | 4 | 47 | 2 | PF06484 | |
| Domain | Notch_NODP_dom | 3.71e-05 | 4 | 47 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 3.71e-05 | 4 | 47 | 2 | IPR010660 | |
| Domain | NOD | 3.71e-05 | 4 | 47 | 2 | SM01338 | |
| Domain | NODP | 3.71e-05 | 4 | 47 | 2 | SM01339 | |
| Domain | cEGF | 3.73e-05 | 26 | 47 | 3 | IPR026823 | |
| Domain | cEGF | 3.73e-05 | 26 | 47 | 3 | PF12662 | |
| Domain | LNR | 6.17e-05 | 5 | 47 | 2 | PS50258 | |
| Domain | YD | 6.17e-05 | 5 | 47 | 2 | IPR006530 | |
| Domain | Notch_dom | 1.29e-04 | 7 | 47 | 2 | IPR000800 | |
| Domain | Notch | 1.29e-04 | 7 | 47 | 2 | PF00066 | |
| Domain | NL | 1.29e-04 | 7 | 47 | 2 | SM00004 | |
| Domain | NHL | 4.75e-04 | 13 | 47 | 2 | PS51125 | |
| Domain | LAMININ_NTER | 7.27e-04 | 16 | 47 | 2 | PS51117 | |
| Domain | Laminin_N | 7.27e-04 | 16 | 47 | 2 | PF00055 | |
| Domain | Laminin_N | 7.27e-04 | 16 | 47 | 2 | IPR008211 | |
| Domain | LamNT | 7.27e-04 | 16 | 47 | 2 | SM00136 | |
| Domain | CarboxyPept-like_regulatory | 8.23e-04 | 17 | 47 | 2 | IPR008969 | |
| Domain | IB | 9.24e-04 | 18 | 47 | 2 | SM00121 | |
| Domain | IGFBP_N_2 | 1.14e-03 | 20 | 47 | 2 | PS51323 | |
| Domain | IGFBP-like | 1.14e-03 | 20 | 47 | 2 | IPR000867 | |
| Domain | IGFBP | 1.14e-03 | 20 | 47 | 2 | PF00219 | |
| Domain | VWC | 2.25e-03 | 28 | 47 | 2 | PF00093 | |
| Domain | EGF_LAM_2 | 2.58e-03 | 30 | 47 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 2.58e-03 | 30 | 47 | 2 | PS01248 | |
| Domain | Laminin_EGF | 3.50e-03 | 35 | 47 | 2 | PF00053 | |
| Domain | EGF_Lam | 3.50e-03 | 35 | 47 | 2 | SM00180 | |
| Domain | VWFC_1 | 3.70e-03 | 36 | 47 | 2 | PS01208 | |
| Domain | VWC | 4.11e-03 | 38 | 47 | 2 | SM00214 | |
| Domain | Laminin_EGF | 4.11e-03 | 38 | 47 | 2 | IPR002049 | |
| Domain | VWFC_2 | 4.11e-03 | 38 | 47 | 2 | PS50184 | |
| Domain | - | 4.33e-03 | 39 | 47 | 2 | 2.120.10.30 | |
| Domain | VWF_dom | 5.01e-03 | 42 | 47 | 2 | IPR001007 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 2.82e-08 | 13 | 37 | 4 | M46426 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 9.24e-07 | 8 | 37 | 3 | M47850 | |
| Pathway | REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS | 3.25e-05 | 70 | 37 | 4 | M46438 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.68e-05 | 25 | 37 | 3 | M39713 | |
| Pathway | WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION | 4.69e-05 | 254 | 37 | 6 | M48344 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 5.82e-05 | 264 | 37 | 6 | M9809 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 6.67e-05 | 5 | 37 | 2 | M27411 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 7.65e-05 | 87 | 37 | 4 | M39465 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.83e-05 | 32 | 37 | 3 | MM14854 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 9.99e-05 | 6 | 37 | 2 | M27068 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.22e-04 | 37 | 37 | 3 | M27134 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.27e-04 | 99 | 37 | 4 | MM14910 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.32e-04 | 38 | 37 | 3 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.43e-04 | 39 | 37 | 3 | MM14601 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.65e-04 | 106 | 37 | 4 | M27200 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.05e-04 | 44 | 37 | 3 | M26969 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.49e-04 | 47 | 37 | 3 | M646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 3.63e-04 | 11 | 37 | 2 | M47865 | |
| Pathway | BIOCARTA_HES_PATHWAY | 4.35e-04 | 12 | 37 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 4.35e-04 | 12 | 37 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 4.35e-04 | 12 | 37 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 4.35e-04 | 12 | 37 | 2 | M47533 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 4.89e-04 | 59 | 37 | 3 | M39886 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.13e-04 | 13 | 37 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 5.13e-04 | 13 | 37 | 2 | M47534 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 8.76e-04 | 72 | 37 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 9.12e-04 | 73 | 37 | 3 | MM15906 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 9.99e-04 | 18 | 37 | 2 | M614 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.05e-03 | 300 | 37 | 5 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.07e-03 | 77 | 37 | 3 | MM14670 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.12e-03 | 176 | 37 | 4 | MM15718 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.24e-03 | 20 | 37 | 2 | M27881 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.30e-03 | 183 | 37 | 4 | M997 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.78e-03 | 24 | 37 | 2 | M11190 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.89e-03 | 94 | 37 | 3 | M1041 | |
| Pathway | REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY | 2.07e-03 | 97 | 37 | 3 | MM15268 | |
| Pathway | REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS | 2.09e-03 | 26 | 37 | 2 | MM15270 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.26e-03 | 27 | 37 | 2 | M39545 | |
| Pathway | REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY | 2.32e-03 | 101 | 37 | 3 | M27552 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.43e-03 | 28 | 37 | 2 | M6177 | |
| Pathway | REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS | 2.60e-03 | 29 | 37 | 2 | M27555 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.78e-03 | 30 | 37 | 2 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.78e-03 | 30 | 37 | 2 | M27216 | |
| Pathway | WP_13Q1212_COPY_NUMBER_VARIATION | 3.57e-03 | 34 | 37 | 2 | M48103 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 3.57e-03 | 34 | 37 | 2 | M39390 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.61e-03 | 118 | 37 | 3 | MM15588 | |
| Pathway | KEGG_PRION_DISEASES | 3.78e-03 | 35 | 37 | 2 | M13036 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 4.15e-03 | 124 | 37 | 3 | M27285 | |
| Pubmed | Identification and characterization of TMEM16E and TMEM16F genes in silico. | 5.66e-11 | 6 | 50 | 4 | 15067359 | |
| Pubmed | ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins. | 1.32e-10 | 7 | 50 | 4 | 22075693 | |
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 20056604 | ||
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 7.88e-10 | 10 | 50 | 4 | 19015192 | |
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 7.88e-10 | 10 | 50 | 4 | 23532839 | |
| Pubmed | 7.88e-10 | 10 | 50 | 4 | 24692353 | ||
| Pubmed | Identification of a dimerization domain in the TMEM16A calcium-activated chloride channel (CaCC). | 2.80e-09 | 3 | 50 | 3 | 23576756 | |
| Pubmed | Putative pore-loops of TMEM16/anoctamin channels affect channel density in cell membranes. | 2.80e-09 | 3 | 50 | 3 | 23613533 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FAT4 FBN1 CRIM1 TENM3 ANO6 LAMB2 LAMC3 CCN2 LTBP1 LTBP3 LTBR NOTCH1 NOTCH2 | 1.01e-08 | 1201 | 50 | 13 | 35696571 |
| Pubmed | 1.89e-08 | 118 | 50 | 6 | 21078624 | ||
| Pubmed | The anoctamin family: TMEM16A and TMEM16B as calcium-activated chloride channels. | 1.56e-07 | 8 | 50 | 3 | 21984732 | |
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 18729231 | ||
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 22946059 | ||
| Pubmed | 1.26e-06 | 15 | 50 | 3 | 17804598 | ||
| Pubmed | Subtypes of medulloblastoma have distinct developmental origins. | 1.41e-06 | 57 | 50 | 4 | 21150899 | |
| Pubmed | A role for notch signaling in human corneal epithelial cell differentiation and proliferation. | 2.03e-06 | 2 | 50 | 2 | 17652726 | |
| Pubmed | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture. | 2.03e-06 | 2 | 50 | 2 | 24508387 | |
| Pubmed | Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas. | 2.03e-06 | 2 | 50 | 2 | 25041344 | |
| Pubmed | Notch controls generation and function of human effector CD8+ T cells. | 2.03e-06 | 2 | 50 | 2 | 23380742 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19907020 | ||
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 2.03e-06 | 2 | 50 | 2 | 26494287 | |
| Pubmed | Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells. | 2.03e-06 | 2 | 50 | 2 | 25866967 | |
| Pubmed | Co-expression of anoctamins in cilia of olfactory sensory neurons. | 2.03e-06 | 2 | 50 | 2 | 25500808 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 32423029 | ||
| Pubmed | The Wnt antagonist Wif-1 interacts with CTGF and inhibits CTGF activity. | 2.03e-06 | 2 | 50 | 2 | 21928342 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23570556 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21466361 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24318978 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20069650 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15625786 | ||
| Pubmed | Notch2 signaling is required for potent antitumor immunity in vivo. | 2.03e-06 | 2 | 50 | 2 | 20351182 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24928056 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22961762 | ||
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 2.03e-06 | 2 | 50 | 2 | 28669633 | |
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 2.03e-06 | 2 | 50 | 2 | 29625025 | |
| Pubmed | Involvement of Notch in activation and effector functions of γδ T cells. | 2.03e-06 | 2 | 50 | 2 | 24489102 | |
| Pubmed | Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. | 2.03e-06 | 2 | 50 | 2 | 17261636 | |
| Pubmed | Cellular and axonal constituents of neocortical molecular layer heterotopia. | 2.03e-06 | 2 | 50 | 2 | 25247689 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 35484136 | ||
| Pubmed | Motch A and motch B--two mouse Notch homologues coexpressed in a wide variety of tissues. | 2.03e-06 | 2 | 50 | 2 | 8440332 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24980868 | ||
| Pubmed | The Notch pathway in podocytes plays a role in the development of glomerular disease. | 2.03e-06 | 2 | 50 | 2 | 18311147 | |
| Pubmed | Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. | 2.03e-06 | 2 | 50 | 2 | 25141821 | |
| Pubmed | Differential expression of Notch1 and Notch2 in developing and adult mouse brain. | 2.03e-06 | 2 | 50 | 2 | 7609614 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 33017398 | ||
| Pubmed | Functional swapping between transmembrane proteins TMEM16A and TMEM16F. | 2.03e-06 | 2 | 50 | 2 | 24478309 | |
| Pubmed | Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. | 2.03e-06 | 2 | 50 | 2 | 21285514 | |
| Pubmed | Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. | 2.03e-06 | 2 | 50 | 2 | 18353145 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 35129434 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22205705 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23571221 | ||
| Pubmed | Notch signaling induces cell cycle arrest in small cell lung cancer cells. | 2.03e-06 | 2 | 50 | 2 | 11306509 | |
| Pubmed | Correlation of asymmetric Notch2 expression and mouse incisor rotation. | 2.03e-06 | 2 | 50 | 2 | 10704869 | |
| Pubmed | Notch signaling is necessary but not sufficient for differentiation of dendritic cells. | 2.03e-06 | 2 | 50 | 2 | 12907456 | |
| Pubmed | Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis. | 2.03e-06 | 2 | 50 | 2 | 26933171 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21693515 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23589286 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8917536 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25489088 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22500639 | ||
| Pubmed | Functional conservation of Notch1 and Notch2 intracellular domains. | 2.03e-06 | 2 | 50 | 2 | 15897231 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 37413709 | ||
| Pubmed | Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis. | 2.03e-06 | 2 | 50 | 2 | 27564686 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 30296524 | ||
| Pubmed | Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. | 2.03e-06 | 2 | 50 | 2 | 12753746 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25982147 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19701457 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26041884 | ||
| Pubmed | Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma. | 2.03e-06 | 2 | 50 | 2 | 28820917 | |
| Pubmed | The role of TMEM16A (ANO1) and TMEM16F (ANO6) in cell migration. | 2.03e-06 | 2 | 50 | 2 | 23832500 | |
| Pubmed | Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. | 2.03e-06 | 2 | 50 | 2 | 22006338 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 30306291 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19339697 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15492845 | ||
| Pubmed | Niclosamide repurposed for the treatment of inflammatory airway disease. | 2.03e-06 | 2 | 50 | 2 | 31391337 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 29643502 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19915064 | ||
| Pubmed | Laminin-Dependent Interaction between Astrocytes and Microglia: A Role in Retinal Angiogenesis. | 2.03e-06 | 2 | 50 | 2 | 28697326 | |
| Pubmed | Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. | 2.03e-06 | 2 | 50 | 2 | 27776108 | |
| Pubmed | Notch Inhibition Prevents Differentiation of Human Limbal Stem/Progenitor Cells in vitro. | 2.03e-06 | 2 | 50 | 2 | 31316119 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18666240 | ||
| Pubmed | Laminin deficits induce alterations in the development of dopaminergic neurons in the mouse retina. | 2.03e-06 | 2 | 50 | 2 | 17711601 | |
| Pubmed | In vivo mapping of notch pathway activity in normal and stress hematopoiesis. | 2.03e-06 | 2 | 50 | 2 | 23791481 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 16272360 | ||
| Pubmed | Creb5 coordinates synovial joint formation with the genesis of articular cartilage. | 2.67e-06 | 19 | 50 | 3 | 36435829 | |
| Pubmed | 4.22e-06 | 22 | 50 | 3 | 15301860 | ||
| Pubmed | Reduced Notch signaling leads to renal cysts and papillary microadenomas. | 6.07e-06 | 3 | 50 | 2 | 20378824 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 22396647 | ||
| Pubmed | Helicobacter pylori Infection of Gastric Epithelial Cells Affects NOTCH Pathway In Vitro. | 6.07e-06 | 3 | 50 | 2 | 27073072 | |
| Pubmed | Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas. | 6.07e-06 | 3 | 50 | 2 | 28796347 | |
| Pubmed | NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells. | 6.07e-06 | 3 | 50 | 2 | 24122995 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19797679 | ||
| Pubmed | Plasma membrane-localized TMEM16 proteins are indispensable for expression of CFTR. | 6.07e-06 | 3 | 50 | 2 | 30915480 | |
| Pubmed | Notch signaling regulates follicular helper T cell differentiation. | 6.07e-06 | 3 | 50 | 2 | 23918982 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 7615640 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 27800305 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 34433575 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 7918097 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 8645602 | ||
| Pubmed | Notch signaling confers antigen-presenting cell functions on mast cells. | 6.07e-06 | 3 | 50 | 2 | 19130928 | |
| Interaction | NTN5 interactions | 2.67e-07 | 24 | 47 | 4 | int:NTN5 | |
| Interaction | DTX4 interactions | 1.77e-05 | 22 | 47 | 3 | int:DTX4 | |
| Interaction | RHOB interactions | 1.91e-05 | 840 | 47 | 10 | int:RHOB | |
| Interaction | CNTN1 interactions | 2.01e-05 | 69 | 47 | 4 | int:CNTN1 | |
| Interaction | IKZF2 interactions | 2.98e-05 | 26 | 47 | 3 | int:IKZF2 | |
| Interaction | DYRK1A interactions | 3.69e-05 | 552 | 47 | 8 | int:DYRK1A | |
| Interaction | FBXO2 interactions | 4.34e-05 | 411 | 47 | 7 | int:FBXO2 | |
| Interaction | TRAF5 interactions | 6.24e-05 | 92 | 47 | 4 | int:TRAF5 | |
| Interaction | LTBP1 interactions | 6.24e-05 | 92 | 47 | 4 | int:LTBP1 | |
| Interaction | WNT10A interactions | 8.74e-05 | 37 | 47 | 3 | int:WNT10A | |
| Interaction | DLL1 interactions | 9.47e-05 | 38 | 47 | 3 | int:DLL1 | |
| Interaction | PSG8 interactions | 1.19e-04 | 41 | 47 | 3 | int:PSG8 | |
| Interaction | HOXA1 interactions | 1.70e-04 | 356 | 47 | 6 | int:HOXA1 | |
| Interaction | ZNF865 interactions | 1.79e-04 | 47 | 47 | 3 | int:ZNF865 | |
| Interaction | CACNA1A interactions | 1.92e-04 | 123 | 47 | 4 | int:CACNA1A | |
| Interaction | ODAPH interactions | 2.03e-04 | 49 | 47 | 3 | int:ODAPH | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q12 | 2.15e-03 | 234 | 50 | 3 | chr13q12 | |
| Cytoband | 12p13 | 2.24e-03 | 64 | 50 | 2 | 12p13 | |
| GeneFamily | Anoctamins | 3.09e-09 | 10 | 37 | 4 | 865 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 3.40e-07 | 29 | 37 | 4 | 782 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 2.44e-05 | 4 | 37 | 2 | 628 | |
| GeneFamily | Laminin subunits | 2.66e-04 | 12 | 37 | 2 | 626 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 4.51e-03 | 49 | 37 | 2 | 584 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.32e-03 | 394 | 37 | 4 | 471 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 1.37e-02 | 87 | 37 | 2 | 372 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | RTKN2 TENM4 TENM3 LAMB2 HEATR5A CCN2 LTBP1 PLP1 NOTCH1 NOTCH2 | 1.20e-09 | 364 | 49 | 10 | M39057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.40e-09 | 191 | 49 | 8 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 3.58e-08 | 270 | 49 | 8 | MM17057 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.73e-08 | 196 | 49 | 7 | M3008 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 4.32e-07 | 681 | 49 | 10 | M39175 | |
| Coexpression | NABA_CORE_MATRISOME | 7.64e-07 | 275 | 49 | 7 | M5884 | |
| Coexpression | HU_FETAL_RETINA_RPE | 1.11e-06 | 291 | 49 | 7 | M39271 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 1.42e-05 | 600 | 49 | 8 | M39055 | |
| Coexpression | NABA_MATRISOME | 1.42e-05 | 1008 | 49 | 10 | MM17056 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 3.46e-05 | 493 | 49 | 7 | M19391 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.49e-05 | 199 | 49 | 5 | M9180 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 3.49e-05 | 199 | 49 | 5 | M7420 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 3.53e-05 | 34 | 49 | 3 | M14043 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 3.57e-05 | 200 | 49 | 5 | M9657 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_UP | 3.57e-05 | 200 | 49 | 5 | M5730 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 5.25e-05 | 721 | 49 | 8 | M1999 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 9.01e-05 | 574 | 49 | 7 | M39056 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | 9.40e-05 | 1012 | 49 | 9 | M40864 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 9.52e-05 | 8 | 49 | 2 | M9884 | |
| Coexpression | NABA_MATRISOME | 1.04e-04 | 1026 | 49 | 9 | M5889 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.13e-04 | 50 | 49 | 3 | M1259 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_SMOOTH_MUSCLE_CELLS | 1.20e-04 | 51 | 49 | 3 | M40209 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.27e-04 | 52 | 49 | 3 | MM1118 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 1.41e-04 | 141 | 49 | 4 | M10381 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.48e-04 | 1074 | 49 | 9 | M1941 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 1.61e-04 | 146 | 49 | 4 | MM973 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.62e-04 | 439 | 49 | 6 | M39054 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 2.47e-04 | 65 | 49 | 3 | M41673 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.57e-04 | 165 | 49 | 4 | M9109 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 2.77e-04 | 485 | 49 | 6 | M8513 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP | 3.15e-04 | 174 | 49 | 4 | M8120 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 3.32e-04 | 322 | 49 | 5 | M39060 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 4.04e-04 | 16 | 49 | 2 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 4.04e-04 | 16 | 49 | 2 | M2207 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP | 4.48e-04 | 191 | 49 | 4 | M8287 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP | 4.48e-04 | 191 | 49 | 4 | M8742 | |
| Coexpression | P53_DN.V1_UP | 4.75e-04 | 194 | 49 | 4 | M2698 | |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_DN | 5.14e-04 | 18 | 49 | 2 | M3506 | |
| Coexpression | GSE3039_B2_VS_B1_BCELL_UP | 5.23e-04 | 199 | 49 | 4 | M6450 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP | 5.23e-04 | 199 | 49 | 4 | M4494 | |
| Coexpression | GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP | 5.23e-04 | 199 | 49 | 4 | M4427 | |
| Coexpression | GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP | 5.23e-04 | 199 | 49 | 4 | M5687 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 5.27e-04 | 767 | 49 | 7 | M39209 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 5.33e-04 | 200 | 49 | 4 | M9496 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN | 5.33e-04 | 200 | 49 | 4 | M5068 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 5.33e-04 | 200 | 49 | 4 | M9411 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN | 5.33e-04 | 200 | 49 | 4 | M7741 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 5.33e-04 | 200 | 49 | 4 | M7755 | |
| Coexpression | GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP | 5.33e-04 | 200 | 49 | 4 | M5819 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP | 5.33e-04 | 200 | 49 | 4 | M9633 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP | 5.33e-04 | 200 | 49 | 4 | M4033 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_DN | 5.33e-04 | 200 | 49 | 4 | M5676 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 5.33e-04 | 200 | 49 | 4 | M7417 | |
| Coexpression | GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP | 5.33e-04 | 200 | 49 | 4 | M5617 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 5.63e-04 | 86 | 49 | 3 | M39248 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 5.85e-04 | 205 | 49 | 4 | M39302 | |
| Coexpression | JONES_OVARY_NK_CELL | 6.23e-04 | 89 | 49 | 3 | M48353 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 6.34e-04 | 567 | 49 | 6 | M2129 | |
| Coexpression | SAFFORD_T_LYMPHOCYTE_ANERGY | 6.43e-04 | 90 | 49 | 3 | M1644 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 6.63e-04 | 212 | 49 | 4 | M39221 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 7.12e-04 | 807 | 49 | 7 | M16651 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 7.47e-04 | 385 | 49 | 5 | M39264 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | 7.59e-04 | 587 | 49 | 6 | M17572 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | 7.83e-04 | 389 | 49 | 5 | M6520 | |
| Coexpression | SAFFORD_T_LYMPHOCYTE_ANERGY | 8.00e-04 | 97 | 49 | 3 | MM692 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 9.26e-04 | 102 | 49 | 3 | M5601 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 9.26e-04 | 610 | 49 | 6 | M3854 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 9.27e-04 | 232 | 49 | 4 | M45800 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | 9.32e-04 | 845 | 49 | 7 | M18090 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 9.69e-04 | 408 | 49 | 5 | M3284 | |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 9.73e-04 | 235 | 49 | 4 | M2256 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 9.99e-04 | 25 | 49 | 2 | M9946 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.41e-05 | 65 | 48 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 1.83e-05 | 370 | 48 | 7 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 2.49e-05 | 388 | 48 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 3.59e-05 | 166 | 48 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 9.22e-05 | 328 | 48 | 6 | GSM605756_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 1.05e-04 | 336 | 48 | 6 | GSM605758_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3 | 1.09e-04 | 338 | 48 | 6 | GSM605763_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3+25+.Sp, 4+ 8- GFP+ 25+, Spleen, avg-3 | 1.20e-04 | 344 | 48 | 6 | GSM399365_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.28e-04 | 114 | 48 | 4 | gudmap_kidney_P3_CapMes_Crym_k2_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 2.30e-04 | 388 | 48 | 6 | GSM605790_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 2.50e-04 | 749 | 48 | 8 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 2.63e-04 | 398 | 48 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3 | 2.89e-04 | 405 | 48 | 6 | GSM605796_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 3.05e-04 | 143 | 48 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | FAT4 FBN1 TENM4 TENM3 FNTB ANO6 TNFRSF19 SLC25A29 PLP1 IKZF4 | 3.08e-04 | 1208 | 48 | 10 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 3.30e-04 | 146 | 48 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 3.37e-04 | 783 | 48 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 3.37e-04 | 783 | 48 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 3.47e-04 | 148 | 48 | 4 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 3.65e-04 | 423 | 48 | 6 | GSM399454_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3+25+.Sp, 4+ 8- GFP+ 25+, Spleen, avg-3 | 6.03e-04 | 73 | 48 | 3 | GSM399365_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 6.08e-04 | 466 | 48 | 6 | GSM777050_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 6.54e-04 | 175 | 48 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.11e-11 | 200 | 49 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.26e-09 | 200 | 49 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.61e-08 | 173 | 49 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-08 | 175 | 49 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-08 | 175 | 49 | 6 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-08 | 175 | 49 | 6 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.14e-08 | 177 | 49 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Mild-Lymphoid-T-Treg|Mild / Condition, Lineage, Cell class and cell subclass | 4.42e-08 | 179 | 49 | 6 | a7c01df7623aa6cee4ed4a341545ba240194ca8b | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 6.11e-08 | 189 | 49 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-08 | 190 | 49 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Treg|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.30e-08 | 190 | 49 | 6 | 0523f1039b39a45a23f2f4444e5b47ed581fc4bb | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Treg|normal_Lymph_Node / Location, Cell class and cell subclass | 6.70e-08 | 192 | 49 | 6 | d2c2a98d331522a3ab7973bfaf4396ef4d684888 | |
| ToppCell | tumor_Lung-T/NK_cells-Treg|tumor_Lung / Location, Cell class and cell subclass | 6.91e-08 | 193 | 49 | 6 | 675645fb2e8e75fedba2ab51f67200961bfd2436 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD4-T_reg|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-08 | 195 | 49 | 6 | 77e4c3b61e42e21bdbdff541465ee7ac5f900f13 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-08 | 196 | 49 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-08 | 196 | 49 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.81e-08 | 197 | 49 | 6 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.29e-08 | 199 | 49 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-08 | 199 | 49 | 6 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.29e-08 | 199 | 49 | 6 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 8.54e-08 | 200 | 49 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 8.54e-08 | 200 | 49 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.54e-08 | 200 | 49 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.54e-08 | 200 | 49 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.54e-08 | 200 | 49 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.43e-07 | 154 | 49 | 5 | b16f3139ce50e70a6a2377b1da7d7877b4000ea1 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.18e-07 | 157 | 49 | 5 | f1c6c313836352271033d23efd31b0f0a8a09e02 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.70e-07 | 159 | 49 | 5 | ae53ab7a1339007d0b245c6c291ac61e5ff5b682 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.70e-07 | 159 | 49 | 5 | b05fda31b77536a1878f55d3199563b53f9420b2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tregs|Liver / Manually curated celltypes from each tissue | 9.26e-07 | 161 | 49 | 5 | e0fd0c5f72d6a2900827e7bc2608ce3b8df5686b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-06 | 168 | 49 | 5 | 63437b3c3a66f953eaed600965ab193f9cc49da2 | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 169 | 49 | 5 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-06 | 170 | 49 | 5 | aeac9de12efc727313946a77823aba8ab7cdfbfb | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-Treg-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-06 | 170 | 49 | 5 | 9a21048b0248a0cae00ec2d71d5056a678495385 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 171 | 49 | 5 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 171 | 49 | 5 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 173 | 49 | 5 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 174 | 49 | 5 | 096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 176 | 49 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-06 | 176 | 49 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-06 | 177 | 49 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-06 | 177 | 49 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Mild-Treg|Mild / Disease group and Cell class | 1.52e-06 | 178 | 49 | 5 | e669fd95278e145f55126d0e6be8fb2d6184dbbd | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.60e-06 | 180 | 49 | 5 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 180 | 49 | 5 | 978728c89497d26287f73974fb738ad9fde61415 | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.60e-06 | 180 | 49 | 5 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-06 | 180 | 49 | 5 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-06 | 181 | 49 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-06 | 182 | 49 | 5 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 182 | 49 | 5 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Control / Disease state, Lineage and Cell class | 1.69e-06 | 182 | 49 | 5 | 31bb838cc2900f3c9da9f835d79d557a08abb928 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 184 | 49 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | (1)_T_cells-(1)_T_regulatory|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.79e-06 | 184 | 49 | 5 | 3cbf81757653652441843d85cb7ec1dcf25ca1b0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 184 | 49 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-06 | 184 | 49 | 5 | 08bff25390e3484b75c860738396a405141b69fd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 184 | 49 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 185 | 49 | 5 | ea3ff0bd3f312bd2e93227ecf6ed577366aab3e0 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.83e-06 | 185 | 49 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 1.83e-06 | 185 | 49 | 5 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.83e-06 | 185 | 49 | 5 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 1.83e-06 | 185 | 49 | 5 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.88e-06 | 186 | 49 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-06 | 186 | 49 | 5 | bca5215d406f1785bf3a420201d5686071fcaca5 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Tregs|bone_marrow / Manually curated celltypes from each tissue | 1.93e-06 | 187 | 49 | 5 | bda716a64262325e6e68b281caf131f1840fd298 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.98e-06 | 188 | 49 | 5 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.98e-06 | 188 | 49 | 5 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 188 | 49 | 5 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 2.04e-06 | 189 | 49 | 5 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-06 | 189 | 49 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Treg|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.09e-06 | 190 | 49 | 5 | 632b9541371483d25948b6f033863c49f38e3603 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 190 | 49 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_reg|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.09e-06 | 190 | 49 | 5 | ff42af092173c2d4472bb9a02f5a334c272e05a0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 190 | 49 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-Treg-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-06 | 190 | 49 | 5 | c3c7de22657a86495939456bc22eac61c93db8b2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-Treg|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-06 | 190 | 49 | 5 | 166119c037d80fee852567a9cc53c4143dd19037 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-regulatory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.09e-06 | 190 | 49 | 5 | b69709323a9f1b368b5a4f87295b9f7fd9c9be8e | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 2.09e-06 | 190 | 49 | 5 | 519356c4925b5b6647e7d763d4084cd9b2e94f0a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 191 | 49 | 5 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 191 | 49 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 191 | 49 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-06 | 191 | 49 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 191 | 49 | 5 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.14e-06 | 191 | 49 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 192 | 49 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | metastatic_Brain-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 2.20e-06 | 192 | 49 | 5 | 7c6f44716fc684b0297f266f04968e26fabdf6e3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue | 2.20e-06 | 192 | 49 | 5 | 04bd6e135733570e877af9460f87379ed0a5c5f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 192 | 49 | 5 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | ILEUM-inflamed-(1)_Tregs|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.20e-06 | 192 | 49 | 5 | 1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-06 | 193 | 49 | 5 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 2.26e-06 | 193 | 49 | 5 | bac302e69455aaaf1c18f3272bb213242664d747 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 193 | 49 | 5 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 193 | 49 | 5 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 193 | 49 | 5 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.26e-06 | 193 | 49 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_regulatory_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.26e-06 | 193 | 49 | 5 | 28138c35ea82c6b2163f0cae045ca55859347c73 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.26e-06 | 193 | 49 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 193 | 49 | 5 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass | 2.26e-06 | 193 | 49 | 5 | 51fd629e91c85881c3231486d6d2fb2c65fcd77b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-06 | 193 | 49 | 5 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 194 | 49 | 5 | 91205b22650e7ecdb72bb59348ce2530b76c532c | |
| Computational | DRG (dorsal root ganglia) genes. | 3.86e-04 | 384 | 28 | 6 | MODULE_2 | |
| Computational | IGFBPs. | 4.25e-04 | 12 | 28 | 2 | MODULE_190 | |
| Drug | T16AInh-A01 | 4.35e-06 | 2 | 48 | 2 | ctd:C578466 | |
| Drug | digallic acid | 4.35e-06 | 2 | 48 | 2 | ctd:C067648 | |
| Disease | eosinophil count | CXCR5 CDIP1 IKZF2 CD177 FNTB TNFRSF14 ANO1 LTBP3 LTBR RPH3A NOTCH1 NOTCH2 IKZF4 | 6.20e-07 | 1488 | 49 | 13 | EFO_0004842 |
| Disease | colorectal cancer (implicated_via_orthology) | 1.69e-05 | 30 | 49 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.06e-05 | 32 | 49 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Geleophysic dysplasia | 2.69e-05 | 5 | 49 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 2.69e-05 | 5 | 49 | 2 | C0265287 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 5.64e-05 | 7 | 49 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 5.64e-05 | 7 | 49 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Cancer of Nasopharynx | 9.65e-05 | 9 | 49 | 2 | C0238301 | |
| Disease | Nasopharyngeal Neoplasms | 9.65e-05 | 9 | 49 | 2 | C0027439 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.13e-04 | 670 | 49 | 7 | EFO_0006335, EFO_0006336 | |
| Disease | eosinophil percentage of leukocytes | 2.19e-04 | 746 | 49 | 7 | EFO_0007991 | |
| Disease | macula measurement | 2.76e-04 | 189 | 49 | 4 | EFO_0008375 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.80e-04 | 15 | 49 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.80e-04 | 15 | 49 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.80e-04 | 15 | 49 | 2 | C0154091 | |
| Disease | Child Behaviour Checklist assessment | 4.06e-04 | 18 | 49 | 2 | EFO_0005661 | |
| Disease | Carcinoma of bladder | 4.06e-04 | 18 | 49 | 2 | C0699885 | |
| Disease | pulse pressure measurement | 4.20e-04 | 1392 | 49 | 9 | EFO_0005763 | |
| Disease | obesity (implicated_via_orthology) | 4.49e-04 | 215 | 49 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | ankylosing spondylitis | 4.72e-04 | 91 | 49 | 3 | EFO_0003898 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 5.04e-04 | 20 | 49 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 5.35e-04 | 95 | 49 | 3 | C0279626 | |
| Disease | Cerebral Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0334583 | |
| Disease | Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 7.91e-04 | 25 | 49 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 7.91e-04 | 25 | 49 | 2 | C0338070 | |
| Disease | glycerol measurement | 8.56e-04 | 26 | 49 | 2 | EFO_0010115 | |
| Disease | brain cancer (implicated_via_orthology) | 8.56e-04 | 26 | 49 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 8.56e-04 | 26 | 49 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 8.56e-04 | 26 | 49 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 8.56e-04 | 26 | 49 | 2 | C0334582 | |
| Disease | amino acid measurement | 8.69e-04 | 678 | 49 | 6 | EFO_0005134 | |
| Disease | tonsillectomy risk measurement | 9.14e-04 | 260 | 49 | 4 | EFO_0007924 | |
| Disease | Anaplastic astrocytoma | 9.23e-04 | 27 | 49 | 2 | C0334579 | |
| Disease | autoimmune thyroid disease | 1.21e-03 | 126 | 49 | 3 | EFO_0006812 | |
| Disease | Adult T-Cell Lymphoma/Leukemia | 1.22e-03 | 31 | 49 | 2 | C0023493 | |
| Disease | Squamous cell carcinoma of lung | 1.30e-03 | 32 | 49 | 2 | C0149782 | |
| Disease | Hereditary Diffuse Gastric Cancer | 1.42e-03 | 293 | 49 | 4 | C1708349 | |
| Disease | cervical cancer | 1.46e-03 | 34 | 49 | 2 | C4048328 | |
| Disease | Stomach Neoplasms | 1.49e-03 | 297 | 49 | 4 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.55e-03 | 300 | 49 | 4 | C0024623 | |
| Disease | Uterine Cervical Neoplasm | 1.55e-03 | 35 | 49 | 2 | C0007873 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGCDLGCCLIPCLIN | 171 | Q9H305 | |
| IGGQMIMCPLCDQVC | 346 | Q75V66 | |
| MCEFLGLAHCCLNPM | 306 | P32302 | |
| GKLCCQMCEPGTFLV | 36 | P26842 | |
| TCEMVVACLGVLCPQ | 4461 | Q6V0I7 | |
| LRCPVCLSMEGCLEG | 131 | Q8N6Q3 | |
| EECAPGGCLMELCIQ | 666 | Q9NQ90 | |
| AVECCPNCRGTGMQI | 146 | P31689 | |
| IGGKIIMCPQCDRLC | 341 | Q4KMQ2 | |
| DVCPQMPCLNGGTCA | 1306 | Q04721 | |
| TCLDQIGEFQCICMP | 466 | P46531 | |
| CLCLGCVNPFTMQED | 121 | Q9UHF5 | |
| SCCPCGLQEMEVQAP | 161 | Q9NRY6 | |
| QNGGMCLRPQLCVCK | 196 | Q14766 | |
| GRCQLCECSGNIDPM | 981 | P55268 | |
| CAPGGCLMELCIQLS | 651 | Q5XXA6 | |
| KLKCDVCGMVCIGPN | 111 | Q9UKS7 | |
| CVVEKNGPMCRCRQG | 2036 | Q5VYJ5 | |
| CLLGCAVMQDNPDCL | 1026 | Q86XA9 | |
| GCINNPVALMCEQLG | 441 | Q8NB78 | |
| ECETPGICMNGRCVN | 616 | P35555 | |
| CLDGAVGCMPLCSMD | 126 | P29279 | |
| AGLCCRLVVPCHKGM | 236 | P06241 | |
| CLNGREMCALITCPV | 631 | Q9NZV1 | |
| EMCALITCPVPACGN | 636 | Q9NZV1 | |
| AAGAIQCVICCPMEL | 101 | Q8N8R3 | |
| VVCPLPCMNGGQCSS | 111 | Q9NS15 | |
| QEYILMCCQCPAGGL | 336 | P49356 | |
| DLCNLCAPPDMCDVG | 1176 | Q9NZJ4 | |
| CDVCGMVCIGPNVLM | 161 | Q9H2S9 | |
| ECNCENLIMPTCEVG | 2076 | Q3ZCN5 | |
| GIPGTEAMNGCMICL | 191 | Q13371 | |
| GNMCCRLVAQPACMA | 271 | Q8IZC4 | |
| CGEQLGMLGSACVVC | 101 | Q9Y2J0 | |
| GVICLISCLSPEMNC | 641 | Q9H3W5 | |
| CGVSECIIMGIPMNI | 1341 | O14802 | |
| PEQMGLAPCCTQALC | 706 | Q9Y2I6 | |
| CLVMGCITVLLGCAG | 61 | Q9UKR8 | |
| CICMDGRADLILPCA | 156 | Q8WVD5 | |
| GDGLVDCMDPDCCLQ | 846 | Q6N022 | |
| QCIDPQCGGRGICIM | 581 | Q9P273 | |
| KALCTPRCMNGGLCV | 211 | Q9Y5W5 | |
| TICQLCRPCDPVMGL | 96 | P36941 | |
| GLIMNCCEQCGEYLP | 461 | Q9UBW7 | |
| LCCAVLCLLGAVPME | 6 | A0A589 | |
| GPVRLLPSMCCEEAC | 246 | Q9NS68 | |
| SKCLQCQMCDPAMGL | 91 | Q92956 | |
| LCCAVLCLLGAVPME | 6 | A0A539 | |
| ALPALVCIMCCLFGV | 36 | Q66K66 | |
| EQMPCDPVTGQCSCL | 876 | Q9Y6N6 | |
| MGLLECCARCLVGAP | 1 | P60201 |